Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
about
Targeted therapies in sarcomas: challenging the challengeA Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaPazopanib in the management of advanced soft tissue sarcomasUK guidelines for the management of bone sarcomasGiant-cell tumor of bone: treatment options and role of denosumabModeling human endothelial cell transformation in vascular neoplasiasPazopanib, a new therapy for metastatic soft tissue sarcomaA novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyAddition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case SeriesSystemic therapy options for unresectable and metastatic chordomas.The evolution of systemic therapy in sarcoma.Phase II study on lapatinib in advanced EGFR-positive chordoma.Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.A unique case of distant skin metastasis from chondroid chordomaSystemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case seriesBest practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study.Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyThe clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursClinical management of secondary angiosarcoma after breast conservation therapyEnhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.Solitary fibrous tumour of the pleura: A case report.Combining targeted agents with modern radiotherapy in soft tissue sarcomas.Pazopanib for the treatment of soft-tissue sarcoma.Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.Emerging therapies for adult soft tissue sarcoma.Emerging therapeutic targets for synovial sarcoma.A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.The off-label use of targeted therapies in sarcomas: the OUTC'S programTargeting the tumor microenvironment: focus on angiogenesis.A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.Targeted therapy in sarcomas other than GIST tumorsEfficacy of Tie2 receptor antagonism in angiosarcomaSunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approachesSystemic treatment in advanced soft tissue sarcoma: what is standard, what is new.
P2860
Q21285014-4B163B7D-CB2F-40FE-BCB9-A1D0BF75B831Q26741817-42DB0003-0F85-4240-B2EE-D02E037FB9E7Q26746205-A1D00A20-4085-4CBF-81C4-4B35D2C61B94Q26752425-CF7EDAD4-6FC5-4B35-9633-23ED40458557Q26800332-3F863C8E-3856-42A6-BEF2-6358A23C42D8Q26860203-B1CD62A5-6DAA-4FD3-B203-F1CF2A610AC9Q28287163-BABF08F4-6C9A-424E-B495-9E8CEBB94C67Q28534867-11324DA1-24B7-4587-B1BF-12A3218EA4DFQ28550228-DC0426FC-BFEA-4557-87A7-0EDD6524801CQ33274146-29C97E76-178F-4901-A390-C58329FC075BQ33274710-157019BD-7486-41AB-96F4-49F26B539BAFQ33274760-D003F51E-80DD-47B4-BB50-8ED1FC41EC8AQ33275786-FF8A3857-9324-4716-82CC-C0AE63BB6A61Q33275970-86B30932-FAAF-41E4-B4C2-0650BB46ECA4Q33276109-A16BAD23-B4B7-4568-9AB5-7E3EE0E6FF01Q33276267-591F57DE-41A2-4037-9E7F-040EE2EEBD1EQ33276384-FDBB5E34-EF8A-4BE6-AD2B-773D1A613DC6Q33395853-E17288A2-7C32-490F-8EF1-717C2E7566F4Q33396181-46E8E35B-78AB-4960-A5EC-1897F3F4D047Q33408668-72F21571-D0D5-48D4-B780-0F88022428B2Q33416940-0D0DDEA6-36B2-4171-9296-5044EB38D64BQ33430673-BEE3CAF5-0F8E-4B9F-A898-8B44ADCB1181Q33433105-36C22810-3209-4A75-8D7A-0C7C8C2C174BQ33751719-14EB6346-9E74-4347-A8AF-25514E5EF0C0Q33910609-51BE9221-1B66-4F7C-986D-B3C3D4F4767BQ33975264-B3B960F3-C8A2-4196-A742-3A8125148FE4Q34396047-95D2410D-050C-4A75-AC2B-B7A5353FE421Q34645938-8F16731D-64C9-4CF1-8F4D-AB8FEBCE5278Q34652972-7B77FFD8-DA93-4B10-A7B2-22AD196464EBQ34659806-48A81F7A-5614-40D1-8F3E-EEA240DB710BQ34660607-C1B8D453-6A5D-43CC-B1B3-778FC017773BQ34687036-77008E2F-8A4D-4755-9630-2D75A2798056Q34897996-0DF13598-E83C-44B7-86A4-2A185501DD33Q35184806-DC603053-EC69-4DF1-9C6F-283F996CDA65Q35207344-2C5E4966-2E75-4842-BEE7-72F119900D39Q35622367-A0B3F74B-C1C4-4198-8FEB-D3E06EB53A6FQ35836039-5125DB0F-5233-4592-A4D1-799CDFCC7CC8Q35871185-41B73FB3-3F2B-4876-BF74-94D8F38253BFQ36144210-C0697F6C-071A-4FDC-B2F1-223177E2598CQ36389964-416B03D0-4ABC-4857-A890-55ABA6D2DD76
P2860
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@ast
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@en
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@nl
type
label
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@ast
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@en
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@nl
prefLabel
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@ast
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@en
Multicenter phase II trial of ...... stinal stromal tumor sarcomas.
@nl
P2093
P2860
P356
P1476
Multicenter phase II trial of ...... estinal stromal tumor sarcomas
@en
P2093
Andrew J Wagner
Annick D Van den Abbeele
David C Harmon
David R D'Adamo
Gary K Schwartz
Gauri Bhuchar
George D Demetri
James E Butrynski
Jeffrey Morgan
Margaret M O'Mara
P2860
P304
P356
10.1200/JCO.2008.20.9890
P407
P577
2009-05-18T00:00:00Z